Manulife (Manufacturers Life Insurance)’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.31M Sell
76,519
-8,650
-10% -$280K ﹤0.01% 1442
2025
Q4
$2.91M Buy
85,169
+6,292
+8% +$222K ﹤0.01% 1382
2025
Q3
$2.87M Sell
78,877
-3,861
-5% -$131K ﹤0.01% 1390
2025
Q2
$2.6M Sell
82,738
-12,181
-13% -$378K ﹤0.01% 1401
2025
Q1
$2.82M Sell
94,919
-19,232
-17% -$577K ﹤0.01% 1364
2024
Q4
$3.37M Buy
114,151
+6,760
+6% +$214K ﹤0.01% 1358
2024
Q3
$3.34M Sell
107,391
-14,362
-12% -$522K ﹤0.01% 1371
2024
Q2
$4.13M Buy
121,753
+33,003
+37% +$1.68M ﹤0.01% 1244
2024
Q1
$5.77M Sell
88,750
-43,741
-33% -$3M 0.01% 1128
2023
Q4
$9.05M Buy
132,491
+19,004
+17% +$988K 0.01% 893
2023
Q3
$5.89M Buy
113,487
+12,069
+12% +$714K ﹤0.01% 1038
2023
Q2
$6.08M Buy
101,418
+34,852
+52% +$1.99M ﹤0.01% 988
2023
Q1
$3.29M Buy
66,566
+3,024
+5% +$170K ﹤0.01% 1240
2022
Q4
$3.67M Buy
63,542
+5,099
+9% +$287K ﹤0.01% 1201
2022
Q3
$2.68M Buy
58,443
+36,650
+168% +$1.75M ﹤0.01% 1301
2022
Q2
$782K Hold
21,793
﹤0.01% 1763
2022
Q1
$647K Buy
+21,793
New +$550K ﹤0.01% 2022

Other funds holding IMCR

Manulife (Manufacturers Life Insurance)'s IMCR Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Immunocore (IMCR) stake by 10% in Q1 2026, selling an estimated $280K and leaving 76,519 shares worth $2.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1442.

Manulife (Manufacturers Life Insurance) first reported a position in IMCR in Q1 2022 and has held it in 17 quarters since. The position peaked at $9.05M in Q4 2023. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 76,519 shares of Immunocore worth $2.31M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 8,650 Immunocore shares in Q1 2026, an estimated $280K.
  • Immunocore made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1442 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Immunocore in Q1 2022 and has held it in 17 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Immunocore position peaked at $9.05M in Q4 2023.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.